Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-15

Clinical Trial Update: Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder [Phase 4]

View source ↗

Summary

This document provides an update on a Phase 4 trial assessing whether a generic clozapine is equivalent to the orally dissolving Clozapine formulation. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clozapine (Clozapine)
  • Clozapine - Orally dissolving formulation (clozapine)

Snippet

Sponsor: Manhattan Psychiatric Center | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED